Table 4

Final multivariable Poisson regression models for total number of DFEs over the follow-up period

VariableAll patientsMildSevere
 Adjusted IRRp ValueAdjusted IRRp ValueAdjusted IRRp Value
Severity
(vs mild*)
Moderate1.30 (0.96, 1.76) <0.0001
Severe2.77 (2.36, 3.24)
Gender
(male vs female*)
1.10 (0.99, 1.23)0.085
Ethnicity/race
(vs African-American*)
Asian1.22 (0.91, 1.63) 0.028 0.86 (0.54, 1.38) 0.0052 1.55 (0.97, 2.47)0.14
Caucasian0.84 (0.69, 1.03)0.76 (0.58, 0.99)0.98 (0.68, 1.43)
Latino/Hispanic1.07 (0.83, 1.37)1.30 (0.97, 1.74)0.95 (0.58, 1.55)
Age
(≥65 vs <65*)
1.11 (0.96, 1.29)0.150.81 (0.63, 1.05)0.10
BCVA in worse eye
(visual impairment vs normal*)
1.37 (1.19, 1.57) <0.00011.54 (1.31, 1.81) <0.0001
HbA1C documented
(yes vs no*)
1.65 (1.47, 1.86) <0.00011.71 (1.48, 1.97) <0.00011.54 (1.21, 1.97) 0.0006
Blood sugar documented
(yes vs no*)
1.65 (1.43, 1.89) <0.00011.62 (1.36, 1.93) <0.00011.55 (1.20, 2.00) 0.0006
Wears glasses
(yes vs no*)
1.12 (0.99, 1.26)0.072
Current smoking status
(smoker vs no*)
0.72 (0.61, 0.85) <0.00010.76 0.63, 0.91) 0.0020 0.70 (0.49, 1.01) 0.049
Medication (Insulin)
(yes vs no*)
1.10 (0.97, 1.26)0.151.14 (0.99, 1.33)0.076
Non-insulin diabetic medication
(yes vs no*)
0.87 (0.75, 1.01)0.069
Medications (mental health)
(yes vs no*)
0.82 (0.67, 1.01)0.0510.60 (0.34, 1.08)0.070
Cataract
(yes vs no*)
1.12 (0.97, 1.30)0.131.16 (0.98, 1.38)0.090
Glaucoma
(yes vs no*)
1.23 (0.99, 1.53)0.067
Non-diabetic retinal disease
(yes vs no*)
1.71 (1.49, 1.96) <0.00012.27 (1.89, 2.73) <0.00011.38 (1.09, 1.74) 0.0089
Other ocular comorbidity
(yes vs no*)
1.27 (1.13, 1.44) <0.00011.28 (1.11, 1.47) 0.0006
Neighborhood deprivation index
(vs lowest quartile)
Moderately low1.17 (0.97, 1.41) 0.032 1.08 (0.86, 1.36) 0.015 1.17 (0.81, 1.70)0.20
Moderately high0.81 (0.59, 1.12)0.96 (0.68, 1.38)0.70 (0.36, 1.35)
High0.95 (0.68, 1.33)0.54 (0.31, 0.93)1.17 (0.67, 2.05)
Driving distance
(vs 0–5 miles)
5–25 miles1.01 (0.87, 1.17)0.151.10 (0.80, 1.51)0.10
≥25 miles0.83 (0.64, 1.07)0.76 (0.47, 1.22)
  • *Reference group.

  • †Removed from final model via backwards elimination (p>0.2).

  • Bold indicates p values that reach significance.

  • BCVA, best-corrected visual acuity; DFE, dilated fundus exam; HbA1c, hemoglobin A1c; IRR, incidence rate ratio.